Eastern Cooperative Oncology Group

描述（由申请人提供）：贝斯以色列女执事医疗中心（BIDMC）由贝斯以色列和新英格兰女执事医院于1996年合并而成，这两家医院是朗伍德医疗区的两个邻居和主要的哈佛医学院机构。BIDMC的教职员工由一群杰出的基础和临床研究人员组成。BIDMC拥有全国公认的疾病专业中心，包括专注于乳腺癌、黑色素瘤、肾癌、前列腺癌和肝脏恶性肿瘤的中心。BIDMC研究人员积极参与SPORE资助，重点关注乳腺癌、皮肤癌、肾癌、前列腺癌和肺癌。著名的科学专业领域包括：疫苗和细胞因子治疗，血管生成和信号转导抑制。1999年，BIDMC参与了丹娜-法伯/哈佛癌症中心（DF/HCC）的成立，该中心包括所有哈佛医学院附属机构：BIDMC、丹娜-法伯癌症研究所、布里格姆妇女医院、马萨诸塞州总医院、儿童医院医疗中心、哈佛医学院和哈佛公共卫生学院。DF/HCC的形成将大大提高ECOG和CTSU试验的累积能力。

DESCRIPTION (provided by applicant): Beth Israel Deaconess Medical Center (BIDMC) resulted from the 1996 merger of the Beth Israel and New England Deaconess Hospitals, two neighbors and major Harvard Medical School Institutions in the Longwood Medical area. The BIDMC faculty consists of an exceptional group of committed basic and clinical researchers. BIDMC is home to nationally recognized diseased-based centers of special expertise including those focusing on breast cancer, melanoma, renal cancer, prostate cancer and hepatic malignancies. BIDMC investigators are active participants in SPORE grants focused on Breast, Skin, Renal, Prostate and Lung Cancers. Areas of renowned scientific expertise include: vaccine and cytokine therapy, angiogenesis and signal transduction inhibition. In 1999, the BIDMC participated in the founding of the Dana-Farber/Harvard Cancer Center (DF/HCC), which includes all Harvard Medical School affiliated institutions: BIDMC, Dana-Farber Cancer Institute, Brigham and Woman's Hospital, Massachusetts General Hospital, Children's Hospital Medical Center, Harvard Medical School and Harvard School of Public Health. The formation of DF/HCC will greatly enhance the ability to accrue to ECOG and CTSU trials. BIDMC has been a main ECOG Institution since 1997 and is very committed to clinical research. Over the last five years BIDMC has consistently recruited over 50 patients to therapeutic and prevention trials a year. BIDMC has successfully enrolled over 310 patients from January 1998 to December 2002. To date, in 2003, BIDMC has recruited 43 patients. In order to facilitate successful patient enrollment, BIDMC has significantly increased the number of data managers, nurses and support staff working on ECOG trials. We are committed to further our growth in laboratory and clinical research and increase our administrative participation in EOCG.